首页 > 最新文献

American journal of cardiovascular disease最新文献

英文 中文
Gender in post-cardiac transplant patients has no effect on the occurrence of death, major cardiovascular events or development of cardiac allograft vasculopathy. 心脏移植后患者的性别对死亡、主要心血管事件或异体心脏移植血管病变的发生没有影响。
IF 1.3 Pub Date : 2025-04-25 eCollection Date: 2025-01-01 DOI: 10.62347/LPLW4777
Nishant Satapathy, Mohammad Reza Movahed

Objectives: The effect of gender on outcome in post-cardiac transplant morbidity and mortality including the occurrence of transplant vasculopathy is not well established. The goal of this study was to evaluate adverse post-transplant outcomes based on gender with a focus on cardiac allograft vasculopathy (CAV).

Methods: Using our post-transplant database at the University of Arizona, the effect of gender after heart transplantation on death, major adverse cardiac events (MACE defined as the combined occurrence of myocardial infarction, percutaneous coronary intervention, coronary bypass surgery, re-transplantation, and death) and the occurrence of CAV was evaluated retrospectively over 3 years.

Results: A total of 149 patients were evaluated in our database. Over the study period after the first year post-transplantation, a total of 4,7% deaths occurred. There were no differences in death between males and females (4.3% vs 6.1%, p = ns). MACE occurred in similar degrees between males and females (7.8% vs 9.1%, p = ns). Furthermore, the occurrence of an abnormal coronary angiogram or significant intima thickening seen during intracoronary ultrasound studies was similar between the genders for every year studied.

Conclusions: Gender does not effect on the occurrence of CAV at any year's post-cardiac transplantation. Furthermore, it has no effect on MACE and mortality.

目的:性别对心脏移植术后发病率和死亡率(包括移植血管病变的发生)的影响尚不明确。本研究的目的是评估基于性别的移植后不良结果,重点是心脏异体移植血管病变(CAV)。方法:利用我们在亚利桑那大学的移植后数据库,回顾性评估心脏移植后性别对死亡、主要心脏不良事件(MACE定义为心肌梗死、经皮冠状动脉介入治疗、冠状动脉搭桥手术、再移植和死亡的合并发生)和CAV发生的影响,时间超过3年。结果:在我们的数据库中共评估了149例患者。在移植后第一年的研究期间,总共发生了4.7%的死亡。男性和女性之间的死亡率没有差异(4.3% vs 6.1%, p = ns)。男性和女性的MACE发生率相似(7.8% vs 9.1%, p = ns)。此外,在每年的研究中,冠状动脉造影异常或冠状动脉内超声检查中发现的明显内膜增厚的发生率在性别之间是相似的。结论:性别对心脏移植后任何年份CAV的发生均无影响。此外,它对MACE和死亡率没有影响。
{"title":"Gender in post-cardiac transplant patients has no effect on the occurrence of death, major cardiovascular events or development of cardiac allograft vasculopathy.","authors":"Nishant Satapathy, Mohammad Reza Movahed","doi":"10.62347/LPLW4777","DOIUrl":"10.62347/LPLW4777","url":null,"abstract":"<p><strong>Objectives: </strong>The effect of gender on outcome in post-cardiac transplant morbidity and mortality including the occurrence of transplant vasculopathy is not well established. The goal of this study was to evaluate adverse post-transplant outcomes based on gender with a focus on cardiac allograft vasculopathy (CAV).</p><p><strong>Methods: </strong>Using our post-transplant database at the University of Arizona, the effect of gender after heart transplantation on death, major adverse cardiac events (MACE defined as the combined occurrence of myocardial infarction, percutaneous coronary intervention, coronary bypass surgery, re-transplantation, and death) and the occurrence of CAV was evaluated retrospectively over 3 years.</p><p><strong>Results: </strong>A total of 149 patients were evaluated in our database. Over the study period after the first year post-transplantation, a total of 4,7% deaths occurred. There were no differences in death between males and females (4.3% vs 6.1%, p = ns). MACE occurred in similar degrees between males and females (7.8% vs 9.1%, p = ns). Furthermore, the occurrence of an abnormal coronary angiogram or significant intima thickening seen during intracoronary ultrasound studies was similar between the genders for every year studied.</p><p><strong>Conclusions: </strong>Gender does not effect on the occurrence of CAV at any year's post-cardiac transplantation. Furthermore, it has no effect on MACE and mortality.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 2","pages":"115-122"},"PeriodicalIF":1.3,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12089021/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144118578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impacts of armed conflict on outcomes of coronary angiography: report from Sudan's hot war zone 2023-2024. 武装冲突对冠状动脉造影结果的影响:来自苏丹热战区2023-2024年的报告
IF 1.3 Pub Date : 2025-04-25 eCollection Date: 2025-01-01 DOI: 10.62347/IJAI8338
Eldisugi Hassan Mohammed Humida, Salah Mohamed Ibrahim Mohamed, Abdelsalam Mohamed Hamad Elfaki, Khalid Me Eltalib, Amal Khalil Yousif Mohammed, Rayan Eissa Elbadwi Alhaj, Hussain Gadelkarim Ahmed

Objectives: Coronary angiography and emergency coronary revascularizations are critical for decreasing morbidity and mortality linked to coronary artery disease. Establishing and maintaining this service in armed conflict and on the battlefield poses challenges; however, it remains achievable. This study aimed to evaluate the results of coronary angiography in Sudan amid the armed conflict of 2023-2024.

Methods: This study utilized a retrospective descriptive analysis conducted at El-Obeid International Hospital (Aldaman) in North Kordofan State, Sudan. Patient data was obtained from the hospital for the period spanning April 15, 2023, to April 30, 2024.

Results: Out of 314 diagnostic coronary angiograms, 32% had PCI with DES implantation, 18% showed normal coronary arteries, and the other 50% were treated with medication and advice from heart surgeons (CTC). Among the 100 patients who underwent PCI, 64% were male and 36% were female. The predominant age group was 50-59 years, succeeded by 60-69 years, under 50 years, and over 60 years, with incidence rates of 30%, 29.9%, 20.3%, and 18.2%, respectively.

Conclusions: The offering of cardiac catheterization laboratory services amid armed conflict poses challenges but is nonetheless feasible. Despite the tragedy, constrained resources, and the impact of wartime conditions, our findings were consistent with prior reports both locally and globally.

目的:冠状动脉造影和紧急冠状动脉血管重建术对于降低与冠状动脉疾病相关的发病率和死亡率至关重要。在武装冲突和战场上建立和维持这一服务构成挑战;然而,这仍然是可以实现的。本研究旨在评估2023-2024年武装冲突期间苏丹冠状动脉造影的结果。方法:本研究采用在苏丹北科尔多凡州El-Obeid国际医院(Aldaman)进行的回顾性描述性分析。从该医院获得了2023年4月15日至2024年4月30日期间的患者数据。结果:在314例诊断性冠状动脉造影中,32%行PCI合并DES植入,18%冠状动脉正常,另外50%接受了心脏外科医生(CTC)的药物治疗和建议。100例行PCI的患者中,男性占64%,女性占36%。发病年龄以50 ~ 59岁为主,其次为60 ~ 69岁、50岁以下、60岁以上,发病率分别为30%、29.9%、20.3%、18.2%。结论:在武装冲突中提供心导管实验室服务存在挑战,但仍然是可行的。尽管有悲剧、有限的资源和战时条件的影响,我们的调查结果与当地和全球之前的报告一致。
{"title":"The impacts of armed conflict on outcomes of coronary angiography: report from Sudan's hot war zone 2023-2024.","authors":"Eldisugi Hassan Mohammed Humida, Salah Mohamed Ibrahim Mohamed, Abdelsalam Mohamed Hamad Elfaki, Khalid Me Eltalib, Amal Khalil Yousif Mohammed, Rayan Eissa Elbadwi Alhaj, Hussain Gadelkarim Ahmed","doi":"10.62347/IJAI8338","DOIUrl":"10.62347/IJAI8338","url":null,"abstract":"<p><strong>Objectives: </strong>Coronary angiography and emergency coronary revascularizations are critical for decreasing morbidity and mortality linked to coronary artery disease. Establishing and maintaining this service in armed conflict and on the battlefield poses challenges; however, it remains achievable. This study aimed to evaluate the results of coronary angiography in Sudan amid the armed conflict of 2023-2024.</p><p><strong>Methods: </strong>This study utilized a retrospective descriptive analysis conducted at El-Obeid International Hospital (Aldaman) in North Kordofan State, Sudan. Patient data was obtained from the hospital for the period spanning April 15, 2023, to April 30, 2024.</p><p><strong>Results: </strong>Out of 314 diagnostic coronary angiograms, 32% had PCI with DES implantation, 18% showed normal coronary arteries, and the other 50% were treated with medication and advice from heart surgeons (CTC). Among the 100 patients who underwent PCI, 64% were male and 36% were female. The predominant age group was 50-59 years, succeeded by 60-69 years, under 50 years, and over 60 years, with incidence rates of 30%, 29.9%, 20.3%, and 18.2%, respectively.</p><p><strong>Conclusions: </strong>The offering of cardiac catheterization laboratory services amid armed conflict poses challenges but is nonetheless feasible. Despite the tragedy, constrained resources, and the impact of wartime conditions, our findings were consistent with prior reports both locally and globally.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 2","pages":"131-138"},"PeriodicalIF":1.3,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12089026/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144118596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous coronary intervention in elderly patients: clinical benefits and challenges from single center experience. 老年患者经皮冠状动脉介入治疗:来自单一中心经验的临床益处和挑战。
IF 1.3 Pub Date : 2025-04-25 eCollection Date: 2025-01-01 DOI: 10.62347/DGQV8894
Ani A Rapyan, Armine S Chopikyan, Zinaida T Jndoyan, Ani R Tavaratsyan, Ani S Kocharyan, Shant H Mahrokhian, Hamayak S Sisakian

Objectives: Elderly patients who present with acute myocardial infarction are at increased risk for adverse outcomes owing to higher comorbidity burden and complicated coronary anatomy. We evaluated the three-year outcomes following coronary revascularization compared to conservative management among elderly patients presenting with acute myocardial infarction.

Methods: 155 patients over 75 years of age who were admitted for acute myocardial infarction underwent invasive treatment with coronary angioplasty (n=58) or only medical treatment (n=97). The Kaplan-Meier log rank test was used to compare 3-year survival and rehospitalization probability and the Mantel-Cox log rank test was used to compare mean survival time between groups.

Results: In the Invasive treatment group (ITG) cohort, 3-year survival probability was 74.1% as compared to 29.9% in the Conservative treatment group (CTG) cohort (P<0.001). Mean survival time at 3 years of follow-up was 31.50 (95% CI 29.35-33.65) months among ITG patients versus 24.65 (95% CI 22.71-26.59) months among CTG patients (P<0.001). Mean time to rehospitalization at 3 years was 34.05 (95% CI 32.37-35.72) in the ITG cohort compared to 30.03 (95% CI 28.13-31.93) in the CTG cohort (P=0.004).

Conclusion: Coronary revascularization among elderly patients with acute myocardial infarction reduces both all-cause mortality and cardiovascular events at 3-year follow-up. However, rates of rehospitalizations remain statistically similar between groups. Moreover, invasive treatment imparted improved rehospitalization probability compared to conservative treatment. This observation can be partially explained by a reduction in the frequency of myocardial infarction among those who underwent invasive treatment. While a thorough clinical assessment is required prior to treatment determination among elderly patients with acute myocardial infarction, coronary revascularization should be strongly considered as an intervention that likely improves overall survival probability.

目的:由于较高的合并症负担和复杂的冠状动脉解剖结构,出现急性心肌梗死的老年患者发生不良后果的风险增加。我们评估了老年急性心肌梗死患者行冠状动脉血运重建术与保守治疗后的三年预后。方法:155例75岁以上急性心肌梗死患者接受有创冠状动脉成形术(n=58)或单纯药物治疗(n=97)。采用Kaplan-Meier对数秩检验比较3年生存率和再住院概率,采用Mantel-Cox对数秩检验比较组间平均生存时间。结果:有创治疗组(ITG) 3年生存率为74.1%,而保守治疗组(CTG) 3年生存率为29.9%。结论:老年急性心肌梗死患者行冠状动脉血运重建术3年随访可降低全因死亡率和心血管事件。然而,两组之间的再住院率在统计上仍然相似。此外,与保守治疗相比,有创治疗提高了再住院的可能性。这一观察结果可以部分解释为在接受侵入性治疗的患者中心肌梗死的频率降低。虽然在确定老年急性心肌梗死患者的治疗方案之前需要进行彻底的临床评估,但冠状动脉血运重建术应被强烈认为是一种可能提高总体生存率的干预措施。
{"title":"Percutaneous coronary intervention in elderly patients: clinical benefits and challenges from single center experience.","authors":"Ani A Rapyan, Armine S Chopikyan, Zinaida T Jndoyan, Ani R Tavaratsyan, Ani S Kocharyan, Shant H Mahrokhian, Hamayak S Sisakian","doi":"10.62347/DGQV8894","DOIUrl":"10.62347/DGQV8894","url":null,"abstract":"<p><strong>Objectives: </strong>Elderly patients who present with acute myocardial infarction are at increased risk for adverse outcomes owing to higher comorbidity burden and complicated coronary anatomy. We evaluated the three-year outcomes following coronary revascularization compared to conservative management among elderly patients presenting with acute myocardial infarction.</p><p><strong>Methods: </strong>155 patients over 75 years of age who were admitted for acute myocardial infarction underwent invasive treatment with coronary angioplasty (n=58) or only medical treatment (n=97). The Kaplan-Meier log rank test was used to compare 3-year survival and rehospitalization probability and the Mantel-Cox log rank test was used to compare mean survival time between groups.</p><p><strong>Results: </strong>In the Invasive treatment group (ITG) cohort, 3-year survival probability was 74.1% as compared to 29.9% in the Conservative treatment group (CTG) cohort (P<0.001). Mean survival time at 3 years of follow-up was 31.50 (95% CI 29.35-33.65) months among ITG patients versus 24.65 (95% CI 22.71-26.59) months among CTG patients (P<0.001). Mean time to rehospitalization at 3 years was 34.05 (95% CI 32.37-35.72) in the ITG cohort compared to 30.03 (95% CI 28.13-31.93) in the CTG cohort (P=0.004).</p><p><strong>Conclusion: </strong>Coronary revascularization among elderly patients with acute myocardial infarction reduces both all-cause mortality and cardiovascular events at 3-year follow-up. However, rates of rehospitalizations remain statistically similar between groups. Moreover, invasive treatment imparted improved rehospitalization probability compared to conservative treatment. This observation can be partially explained by a reduction in the frequency of myocardial infarction among those who underwent invasive treatment. While a thorough clinical assessment is required prior to treatment determination among elderly patients with acute myocardial infarction, coronary revascularization should be strongly considered as an intervention that likely improves overall survival probability.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 2","pages":"123-130"},"PeriodicalIF":1.3,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12089024/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144118593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence for Brugada syndrome diagnosis and gene variants interpretation. 用于 Brugada 综合征诊断和基因变异解释的人工智能。
IF 1.3 Pub Date : 2025-02-15 eCollection Date: 2025-01-01 DOI: 10.62347/YQHQ1079
Mobina Sahebnasagh, Mohammad Hadi Farjoo

Brugada Syndrome (BrS) is a hereditary cardiac condition associated with an elevated risk of lethal arrhythmias, making precise and prompt diagnosis vital to prevent life-threatening outcomes. The diagnosis of BrS is challenging due to the requirement of invasive drug challenge tests, limited human visual capacity to detect subtle electrocardiogram (ECG) patterns, and the transient nature of the disease. Artificial intelligence (AI) can detect almost all patterns of BrS in ECG, some of which are even beyond the capability of expert eyes. AI is subcategorized into several models, with deep learning being considered the most beneficial, boasting its highest accuracy among the other models. With the capability to discriminate subtle data and analyze extensive datasets, AI has achieved higher accuracy, sensitivity, and specificity compared to trained cardiologists. Meanwhile, AI proficiency in managing complex data enables us to discover unclassified genetic variants. AI can also analyze data extracted from induced pluripotent stem cell-derived cardiomyocytes to distinguish BrS from other inherited cardiac arrhythmias. The aim of this study is to present a synopsis of the evolution of various algorithms of artificial intelligence utilized in the diagnosis of BrS and compare their diagnostic abilities to trained cardiologists. In addition, the application of AI for classification of BrS gene variants is also briefly discussed.

Brugada综合征(BrS)是一种遗传性心脏病,与致命性心律失常的风险升高有关,因此准确和及时的诊断对于预防危及生命的后果至关重要。BrS的诊断具有挑战性,因为需要进行侵入性药物激发试验,人类的视觉能力有限,无法检测到细微的心电图(ECG)模式,以及疾病的短暂性。人工智能(AI)可以检测到ECG中几乎所有的BrS模式,其中一些甚至超出了专家眼睛的能力。人工智能被细分为几个模型,其中深度学习被认为是最有益的,在其他模型中具有最高的准确性。与训练有素的心脏病专家相比,人工智能具有区分细微数据和分析广泛数据集的能力,具有更高的准确性、灵敏度和特异性。同时,人工智能在管理复杂数据方面的熟练程度使我们能够发现未分类的基因变异。AI还可以分析从诱导多能干细胞衍生的心肌细胞中提取的数据,以区分BrS与其他遗传性心律失常。本研究的目的是简要介绍用于BrS诊断的各种人工智能算法的发展,并将其诊断能力与训练有素的心脏病专家进行比较。此外,还简要讨论了人工智能在BrS基因变异分类中的应用。
{"title":"Artificial intelligence for Brugada syndrome diagnosis and gene variants interpretation.","authors":"Mobina Sahebnasagh, Mohammad Hadi Farjoo","doi":"10.62347/YQHQ1079","DOIUrl":"10.62347/YQHQ1079","url":null,"abstract":"<p><p>Brugada Syndrome (BrS) is a hereditary cardiac condition associated with an elevated risk of lethal arrhythmias, making precise and prompt diagnosis vital to prevent life-threatening outcomes. The diagnosis of BrS is challenging due to the requirement of invasive drug challenge tests, limited human visual capacity to detect subtle electrocardiogram (ECG) patterns, and the transient nature of the disease. Artificial intelligence (AI) can detect almost all patterns of BrS in ECG, some of which are even beyond the capability of expert eyes. AI is subcategorized into several models, with deep learning being considered the most beneficial, boasting its highest accuracy among the other models. With the capability to discriminate subtle data and analyze extensive datasets, AI has achieved higher accuracy, sensitivity, and specificity compared to trained cardiologists. Meanwhile, AI proficiency in managing complex data enables us to discover unclassified genetic variants. AI can also analyze data extracted from induced pluripotent stem cell-derived cardiomyocytes to distinguish BrS from other inherited cardiac arrhythmias. The aim of this study is to present a synopsis of the evolution of various algorithms of artificial intelligence utilized in the diagnosis of BrS and compare their diagnostic abilities to trained cardiologists. In addition, the application of AI for classification of BrS gene variants is also briefly discussed.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 1","pages":"1-12"},"PeriodicalIF":1.3,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928888/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic intervention with trimetazidine improves intracardiac hemodynamics and reduces re-hospitalizations in patients with advanced heart failure. 曲美他嗪代谢干预可改善心内血流动力学,减少晚期心力衰竭患者的再次住院。
IF 1.3 Pub Date : 2025-02-15 eCollection Date: 2025-01-01 DOI: 10.62347/ASXF2065
Hamayak S Sisakian, Nina A Muradyan, Anna V Babayan, Lilit A Sargsyan, Sama A Shamyar, Armine S Chopikyan, Syuzanna A Shahnazaryan

Objectives: We tested whether management with metabolic cytoprotective and antiischemic agent trimetazidine may reduce readmissions in advanced heart failure (HF) patients through the possible improvement of left ventricular ejection fraction (LV EF) and filling pressure.

Methods: This was a single-center prospective open-label study. The study population included initially 40 patients with advanced HF and EF <30%, NYHA III-IV functional class, significant restriction of physical activity and at least 1 hospitalization during the last 12 months. After discharge patients were assigned to additional treatment with trimetazidine 80 mg/daily dose (20 patients) or standard guideline-based pharmacological therapy (20 patients). After enrollment patients underwent a total of four outpatient clinical and echocardiographic examinations (baseline before discharge, 2 weeks, 1, 3 and 6 months after the discharge). The echocardiographic assessment of EF and LV filling pressure by Tissue Doppler were performed blindly.

Results: At 6 months, trimetazidine-treated patients had an improvement of LV EF (from 23.7% to 25%) as compared to controls (from 22.5% to 22.6%). Tissue Doppler study showed a decrease of LV filling pressure in trimetazidine treated group from 15.1 at baseline to 13.7 after 6 months of treatment. In the control group, LV filling pressure remained unchanged (from 16.78 to 16.7) (P<0.001). The rate of hospitalizations for cardiovascular causes was reduced at 6 months (83.3% vs 70.0%).

Conclusions: Treatment with trimetazidine 80 mg/daily in addition to standard guideline-based therapy for 6-months decreased hospitalization, improved systolic function and LV filling pressure in advanced HF patients.

目的:我们测试了代谢性细胞保护和抗缺血性药物曲美他嗪是否可以通过改善左心室射血分数(LV EF)和充血压力来减少晚期心力衰竭(HF)患者的再入院率。方法:这是一项单中心前瞻性开放标签研究。研究人群最初包括40例晚期HF和EF患者。结果:6个月时,曲美他嗪治疗的患者与对照组(从22.5%到22.6%)相比,左室EF改善(从23.7%到25%)。组织多普勒研究显示曲美他嗪治疗组左室充注压由基线时的15.1降至治疗6个月后的13.7。在对照组中,左室充注压保持不变(从16.78到16.7)。(结论:在标准指南治疗基础上加用曲美他嗪80mg /d治疗6个月可降低晚期HF患者住院率,改善收缩功能和左室充注压。
{"title":"Metabolic intervention with trimetazidine improves intracardiac hemodynamics and reduces re-hospitalizations in patients with advanced heart failure.","authors":"Hamayak S Sisakian, Nina A Muradyan, Anna V Babayan, Lilit A Sargsyan, Sama A Shamyar, Armine S Chopikyan, Syuzanna A Shahnazaryan","doi":"10.62347/ASXF2065","DOIUrl":"10.62347/ASXF2065","url":null,"abstract":"<p><strong>Objectives: </strong>We tested whether management with metabolic cytoprotective and antiischemic agent trimetazidine may reduce readmissions in advanced heart failure (HF) patients through the possible improvement of left ventricular ejection fraction (LV EF) and filling pressure.</p><p><strong>Methods: </strong>This was a single-center prospective open-label study. The study population included initially 40 patients with advanced HF and EF <30%, NYHA III-IV functional class, significant restriction of physical activity and at least 1 hospitalization during the last 12 months. After discharge patients were assigned to additional treatment with trimetazidine 80 mg/daily dose (20 patients) or standard guideline-based pharmacological therapy (20 patients). After enrollment patients underwent a total of four outpatient clinical and echocardiographic examinations (baseline before discharge, 2 weeks, 1, 3 and 6 months after the discharge). The echocardiographic assessment of EF and LV filling pressure by Tissue Doppler were performed blindly.</p><p><strong>Results: </strong>At 6 months, trimetazidine-treated patients had an improvement of LV EF (from 23.7% to 25%) as compared to controls (from 22.5% to 22.6%). Tissue Doppler study showed a decrease of LV filling pressure in trimetazidine treated group from 15.1 at baseline to 13.7 after 6 months of treatment. In the control group, LV filling pressure remained unchanged (from 16.78 to 16.7) (P<0.001). The rate of hospitalizations for cardiovascular causes was reduced at 6 months (83.3% vs 70.0%).</p><p><strong>Conclusions: </strong>Treatment with trimetazidine 80 mg/daily in addition to standard guideline-based therapy for 6-months decreased hospitalization, improved systolic function and LV filling pressure in advanced HF patients.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 1","pages":"13-20"},"PeriodicalIF":1.3,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928887/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alternating between exit sites of retrograde slow pathway during fast-slow atrioventricular nodal reentrant tachycardia: case report. 快慢型房室结复律性心动过速时逆行慢速通路出口部位的交替:病例报告。
IF 1.3 Pub Date : 2025-02-15 eCollection Date: 2025-01-01 DOI: 10.62347/XMJR4018
Mihoko Kawabata, Yasuhiro Shirai, Tatsuaki Kamata, Tomoyuki Kawashima, Ryo Yonai, Kaoru Okishige, Kenzo Hirao

We report a case of a 57-year-old male with narrow QRS tachycardia exhibiting the alternance of the cycle length. Differential diagnoses include orthodromic atrioventricular reciprocating tachycardia with alternating antegrade atrioventricular (AV) nodal pathways, atrioventricular nodal re-entrant tachycardia (AVNRT) with alternating AV nodal pathways, and atrial tachycardia with alternating antegrade AV nodal pathways or with Wenckebach periodicity. In electrophysiological study the tachycardia showed alternance in the retrograde atrial conduction sequence and the cycle length. The alternation was caused by that of the HA intervals, between the shorter HA interval with the earliest atrial activation recorded in coronary sinus (CS), and the longer HA interval with that in His bundle region. The tachycardia was diagnosed with fast-slow form of AVNRT exhibiting the alternance of the earliest atrial activation sites. Electroanatomical 3D mapping further revealed that the exit site of retrograde slow pathway (SP) alternated between the left inferior extension (LIE) inside the CS, and the right inferior extension (RIE) in the posterior tricuspid annulus although among conventional electrode catheters the earliest site was the His bundle region. After ablation of the exit site of LIE, the alternation disappeared and fast-slow AVNRT showing a uniform retrograde atrial activation for which the earliest atrial activation site was the exit of RIE sustained. A single application of ablation at this point was insufficient, thereafter conventional SP ablation was added. Then, the ventriculoatrial conduction disappeared and no tachycardia was inducible even with isoproterenol administration. This case is followed by a review of the literature.

我们报告一例57岁男性窄QRS心动过速表现出周期长度的交替。鉴别诊断包括伴房室交变顺行房室(AV)结路的正位房室往复式心动过速,伴房室交变房室结路的房室结再入性心动过速,伴房室交变顺行房室结路或Wenckebach周期的房性心动过速。在电生理研究中,心动过速表现为逆行心房传导序列和周期长度的交替。这种交替是由HA间期的交替引起的,在冠状窦(CS)记录最早心房活动的HA间期较短,而在他束区记录最早心房活动的HA间期较长。心动过速被诊断为快慢形式的AVNRT,表现为最早心房激活位点的交替。电解剖三维图谱进一步显示,逆行缓慢通路(SP)的出口位置在三尖瓣后环的左下伸(LIE)和右下伸(RIE)之间交替,而在常规电极导管中,最早的出口位置是His束区。消融LIE出口部位后,交替消失,快慢AVNRT呈均匀逆行性心房激活,其中最早的心房激活部位为RIE出口。此时单次消融是不够的,随后加入常规SP消融。然后,室房传导消失,即使给药异丙肾上腺素也未诱发心动过速。本案例之后是对文献的回顾。
{"title":"Alternating between exit sites of retrograde slow pathway during fast-slow atrioventricular nodal reentrant tachycardia: case report.","authors":"Mihoko Kawabata, Yasuhiro Shirai, Tatsuaki Kamata, Tomoyuki Kawashima, Ryo Yonai, Kaoru Okishige, Kenzo Hirao","doi":"10.62347/XMJR4018","DOIUrl":"10.62347/XMJR4018","url":null,"abstract":"<p><p>We report a case of a 57-year-old male with narrow QRS tachycardia exhibiting the alternance of the cycle length. Differential diagnoses include orthodromic atrioventricular reciprocating tachycardia with alternating antegrade atrioventricular (AV) nodal pathways, atrioventricular nodal re-entrant tachycardia (AVNRT) with alternating AV nodal pathways, and atrial tachycardia with alternating antegrade AV nodal pathways or with Wenckebach periodicity. In electrophysiological study the tachycardia showed alternance in the retrograde atrial conduction sequence and the cycle length. The alternation was caused by that of the HA intervals, between the shorter HA interval with the earliest atrial activation recorded in coronary sinus (CS), and the longer HA interval with that in His bundle region. The tachycardia was diagnosed with fast-slow form of AVNRT exhibiting the alternance of the earliest atrial activation sites. Electroanatomical 3D mapping further revealed that the exit site of retrograde slow pathway (SP) alternated between the left inferior extension (LIE) inside the CS, and the right inferior extension (RIE) in the posterior tricuspid annulus although among conventional electrode catheters the earliest site was the His bundle region. After ablation of the exit site of LIE, the alternation disappeared and fast-slow AVNRT showing a uniform retrograde atrial activation for which the earliest atrial activation site was the exit of RIE sustained. A single application of ablation at this point was insufficient, thereafter conventional SP ablation was added. Then, the ventriculoatrial conduction disappeared and no tachycardia was inducible even with isoproterenol administration. This case is followed by a review of the literature.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 1","pages":"39-47"},"PeriodicalIF":1.3,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928883/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gender specific echocardiographic prevalence of valvular stenosis and regurgitations in a large inpatient database of 24,265 patients. 由 24,265 名患者组成的大型住院患者数据库中瓣膜狭窄和反流的性别特异性超声心动图患病率。
IF 1.3 Pub Date : 2025-02-15 eCollection Date: 2025-01-01 DOI: 10.62347/HYOC9461
Mohammad Reza Movahed, Ashkan Bahrami, Reza Eshraghi

Introduction: Prevalence of different valvular pathologies has not been reported in female and male patients in large population-based studies. The goal of this study was to report the gender-specific prevalence of various valvular pathologies.

Methods: We retrospectively analyzed 24,265 echocardiograms performed between 1984 and 1998. The prevalence of mitral regurgitation (MR) aortic valve regurgitation (AR) and stenosis (AS), and tricuspid regurgitation (TR) were calculated in female and male patients.

Results: Echocardiograms were performed on 12,926 (53%) female and 11,339 (47%) male patients. Gender-specific echocardiographic prevalence of different valvular abnormalities was as follows: Prevalence of mitral regurgitations was similar in women and men (25% vs 24.7%). Aortic regurgitation was higher in males (5.5 vs 14.9%, P < 0.001). Aortic stenosis prevalence was similar between both genders (2.1 vs 2.3%). Tricuspid valve regurgitations were slightly higher in females (18.5 vs 16.7%, P < 0.001).

Conclusion: In this study, we found a significantly higher prevalence of tricuspid valve regurgitation in women. Aortic regurgitation was more prevalent in men. Aortic stenosis and mitral regurgitation had similar prevalence in both genders.

导读:在大型人群研究中,不同瓣膜病变的患病率在女性和男性患者中尚未报道。本研究的目的是报告不同性别瓣膜病的患病率。方法:回顾性分析1984年至1998年间24265张超声心动图。计算男女患者二尖瓣反流(MR)、主动脉瓣反流(AR)、主动脉瓣狭窄(AS)、三尖瓣反流(TR)的发生率。结果:女性12926例(53%),男性11339例(47%)行超声心动图检查。不同瓣膜异常的性别超声心动图患病率如下:女性和男性二尖瓣反流的患病率相似(25% vs 24.7%)。主动脉反流在男性中较高(5.5% vs 14.9%, P < 0.001)。男女主动脉瓣狭窄患病率相似(2.1% vs 2.3%)。女性三尖瓣反流稍高(18.5% vs 16.7%, P < 0.001)。结论:在这项研究中,我们发现女性三尖瓣反流的患病率明显更高。主动脉反流在男性中更为普遍。主动脉瓣狭窄和二尖瓣反流在两性中的患病率相似。
{"title":"Gender specific echocardiographic prevalence of valvular stenosis and regurgitations in a large inpatient database of 24,265 patients.","authors":"Mohammad Reza Movahed, Ashkan Bahrami, Reza Eshraghi","doi":"10.62347/HYOC9461","DOIUrl":"10.62347/HYOC9461","url":null,"abstract":"<p><strong>Introduction: </strong>Prevalence of different valvular pathologies has not been reported in female and male patients in large population-based studies. The goal of this study was to report the gender-specific prevalence of various valvular pathologies.</p><p><strong>Methods: </strong>We retrospectively analyzed 24,265 echocardiograms performed between 1984 and 1998. The prevalence of mitral regurgitation (MR) aortic valve regurgitation (AR) and stenosis (AS), and tricuspid regurgitation (TR) were calculated in female and male patients.</p><p><strong>Results: </strong>Echocardiograms were performed on 12,926 (53%) female and 11,339 (47%) male patients. Gender-specific echocardiographic prevalence of different valvular abnormalities was as follows: Prevalence of mitral regurgitations was similar in women and men (25% vs 24.7%). Aortic regurgitation was higher in males (5.5 vs 14.9%, P < 0.001). Aortic stenosis prevalence was similar between both genders (2.1 vs 2.3%). Tricuspid valve regurgitations were slightly higher in females (18.5 vs 16.7%, P < 0.001).</p><p><strong>Conclusion: </strong>In this study, we found a significantly higher prevalence of tricuspid valve regurgitation in women. Aortic regurgitation was more prevalent in men. Aortic stenosis and mitral regurgitation had similar prevalence in both genders.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 1","pages":"21-28"},"PeriodicalIF":1.3,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928885/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overcoming therapeutic challenges in a case of refractory chylothorax following blunt abdominal trauma through the utility of cone-beam computed tomography lymphangiography. 利用锥形束计算机断层淋巴管造影克服腹部钝性创伤后难治性乳糜胸一例的治疗挑战。
IF 1.3 Pub Date : 2025-02-15 eCollection Date: 2025-01-01 DOI: 10.62347/QIEZ3054
Hasan Dinc, Sükrü Oguz, Selcuk Akkaya, Elif Merve Bal, Atilla Türkyılmaz, Bekir Sami Karapolat, Celal Tekinbaş

Chylothorax development following blunt abdominal trauma is a rare event. While low volume chylothoraxes usually improve with conservative treatment, invasive interventions are required in high-volume chylothoraxes with daily drainage exceeding 1000 ml. We report a case of a 14-year-old boy who developed high-volume (>3 L/d) chylothorax on the left side following blunt abdominal trauma. The patient did not respond to conservative treatments. He underwent thoracic duct ligation three times, with percutaneous lymphatic interventions, and percutaneous Lipiodol-glue mixture injections under computed tomography (CT) guidance, but all treatments were unsuccessful. We describe the four-month multidisciplinary challenge in this case that was ultimately successfully treated by surgical ligation of aberrant and/or collateral lymphatics draining from the left abdomen to the left pleural cavity, with the help of the novel cone-beam computed tomography (CBCT) lymphangiography (LAG) technique.

钝性腹部创伤后发展乳糜胸是一种罕见的事件。虽然小容量乳糜胸通常通过保守治疗得到改善,但对于每天引流超过1000毫升的大容量乳糜胸,需要进行侵入性干预。我们报告了一个14岁的男孩,他在钝性腹部创伤后出现了左侧大容量(bbb3l /d)乳糜胸。患者对保守治疗无反应。他接受了三次胸导管结扎术,经皮淋巴介入,并在计算机断层扫描(CT)指导下经皮注射脂醇-胶混合物,但所有治疗均不成功。我们描述了在这种情况下,四个月的多学科挑战,最终成功地通过手术结扎异常和/或侧支淋巴管从左腹部引流到左胸膜腔,在新型锥形束计算机断层扫描(CBCT)淋巴管造影(LAG)技术的帮助下。
{"title":"Overcoming therapeutic challenges in a case of refractory chylothorax following blunt abdominal trauma through the utility of cone-beam computed tomography lymphangiography.","authors":"Hasan Dinc, Sükrü Oguz, Selcuk Akkaya, Elif Merve Bal, Atilla Türkyılmaz, Bekir Sami Karapolat, Celal Tekinbaş","doi":"10.62347/QIEZ3054","DOIUrl":"10.62347/QIEZ3054","url":null,"abstract":"<p><p>Chylothorax development following blunt abdominal trauma is a rare event. While low volume chylothoraxes usually improve with conservative treatment, invasive interventions are required in high-volume chylothoraxes with daily drainage exceeding 1000 ml. We report a case of a 14-year-old boy who developed high-volume (>3 L/d) chylothorax on the left side following blunt abdominal trauma. The patient did not respond to conservative treatments. He underwent thoracic duct ligation three times, with percutaneous lymphatic interventions, and percutaneous Lipiodol-glue mixture injections under computed tomography (CT) guidance, but all treatments were unsuccessful. We describe the four-month multidisciplinary challenge in this case that was ultimately successfully treated by surgical ligation of aberrant and/or collateral lymphatics draining from the left abdomen to the left pleural cavity, with the help of the novel cone-beam computed tomography (CBCT) lymphangiography (LAG) technique.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 1","pages":"48-55"},"PeriodicalIF":1.3,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928884/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics and outcomes of patients undergoing percutaneous coronary intervention at Gesund Cardiac and Medical Center, Addis Ababa, Ethiopia, 2024. 2024 年在埃塞俄比亚亚的斯亚贝巴 Gesund 心脏和医疗中心接受经皮冠状动脉介入治疗的患者的临床特征和疗效。
IF 1.3 Pub Date : 2025-02-15 eCollection Date: 2025-01-01 DOI: 10.62347/RIAQ1956
Kesete Eskias, Alemayehu Bekele, Ousman Adal, Heyria Hussien, Lemlem Beza Demisse

Introduction: Percutaneous coronary intervention (PCI) is a critical procedure for improving blood flow by alleviating arterial blockage. However, its availability in Ethiopia is limited because of insufficient resources, staff, and infrastructure.

Objective: To evaluate the clinical characteristics and outcomes of patients who underwent percutaneous coronary intervention at Gesund Cardiac and Medical Center in Addis Ababa, Ethiopia, in 2024.

Methods: This retrospective observational chart review included 224 patients who underwent percutaneous coronary intervention. Data were collected using a standardized checklist, imported into EPI information v7, and analyzed using SPSS v26. A binary logistic regression model was used to identify factors associated with percutaneous coronary intervention.

Results: The study found that most participants (n = 186, 83%) were male, with a mean age of 57.82 ± 11.5 years. Diabetes mellitus was prevalent among participants (n = 135, 60.3%), followed by hypertension (n = 127, 56.7%). A notable portion (n = 31, 13.8%) had previously undergone percutaneous coronary intervention. Most patients presented with typical chest pain, with ST-Elevation Myocardial Infarction (STEMI) being the primary indication for percutaneous coronary intervention. Post-procedure complications includes significant bleeding (n = 6, 2.6%), myocardial infarction (n = 20, 8.9%), death (n = 2, 0.9%), transfer to another hospital (n = 12, 5.4%), and acute kidney injury (n = 16, 7.14%). The use of bare metal stents was significantly associated with transfer to other hospitals (AOR = 5; 95% CI = 1.69-10.29). Male gender (AOR = 0.09; 95% CI = 0.03-0.34) and a history of myocardial infarction (AOR = 10; 95% CI = 2.31-13.31) were linked to an increased risk of post-percutaneous coronary intervention death.

Conclusion and recommendations: Our findings suggest that coronary artery stenosis (CAS) is more prevalent in older individuals and men. Chronic illnesses often coexist with coronary artery stenosis, thereby complicating the prognosis. Interestingly, men exhibited a lower risk of unfavorable outcomes compared to women. Adherence to procedural guidelines and effective management techniques are essential for improving patient outcomes following percutaneous coronary intervention.

导读:经皮冠状动脉介入治疗(PCI)是通过缓解动脉阻塞来改善血液流动的关键手术。然而,由于资源、人员和基础设施不足,其在埃塞俄比亚的可用性有限。目的:评价2024年在埃塞俄比亚亚的斯亚贝巴Gesund心脏和医学中心接受经皮冠状动脉介入治疗的患者的临床特点和预后。方法:回顾性观察224例经皮冠状动脉介入治疗患者。使用标准化检查表收集数据,导入EPI信息v7,并使用SPSS v26进行分析。采用二元logistic回归模型确定与经皮冠状动脉介入治疗相关的因素。结果:研究发现,大多数参与者(n = 186, 83%)为男性,平均年龄57.82±11.5岁。糖尿病在参与者中最为普遍(n = 135, 60.3%),其次是高血压(n = 127, 56.7%)。相当一部分(n = 31, 13.8%)曾接受过经皮冠状动脉介入治疗。大多数患者表现为典型的胸痛,st段抬高型心肌梗死(STEMI)是经皮冠状动脉介入治疗的主要指征。术后并发症包括大出血(n = 6, 2.6%)、心肌梗死(n = 20, 8.9%)、死亡(n = 2, 0.9%)、转院(n = 12, 5.4%)和急性肾损伤(n = 16, 7.14%)。裸金属支架的使用与转院率显著相关(AOR = 5;95% ci = 1.69-10.29)。男性(AOR = 0.09;95% CI = 0.03-0.34)和心肌梗死史(AOR = 10;95% CI = 2.31-13.31)与经皮冠状动脉介入治疗后死亡风险增加有关。结论和建议:我们的研究结果表明冠状动脉狭窄(CAS)在老年人和男性中更为普遍。慢性疾病常与冠状动脉狭窄共存,从而使预后复杂化。有趣的是,与女性相比,男性表现出较低的不良结果风险。遵守手术指南和有效的管理技术对于改善经皮冠状动脉介入治疗后的患者预后至关重要。
{"title":"Clinical characteristics and outcomes of patients undergoing percutaneous coronary intervention at Gesund Cardiac and Medical Center, Addis Ababa, Ethiopia, 2024.","authors":"Kesete Eskias, Alemayehu Bekele, Ousman Adal, Heyria Hussien, Lemlem Beza Demisse","doi":"10.62347/RIAQ1956","DOIUrl":"10.62347/RIAQ1956","url":null,"abstract":"<p><strong>Introduction: </strong>Percutaneous coronary intervention (PCI) is a critical procedure for improving blood flow by alleviating arterial blockage. However, its availability in Ethiopia is limited because of insufficient resources, staff, and infrastructure.</p><p><strong>Objective: </strong>To evaluate the clinical characteristics and outcomes of patients who underwent percutaneous coronary intervention at Gesund Cardiac and Medical Center in Addis Ababa, Ethiopia, in 2024.</p><p><strong>Methods: </strong>This retrospective observational chart review included 224 patients who underwent percutaneous coronary intervention. Data were collected using a standardized checklist, imported into EPI information v7, and analyzed using SPSS v26. A binary logistic regression model was used to identify factors associated with percutaneous coronary intervention.</p><p><strong>Results: </strong>The study found that most participants (n = 186, 83%) were male, with a mean age of 57.82 ± 11.5 years. Diabetes mellitus was prevalent among participants (n = 135, 60.3%), followed by hypertension (n = 127, 56.7%). A notable portion (n = 31, 13.8%) had previously undergone percutaneous coronary intervention. Most patients presented with typical chest pain, with ST-Elevation Myocardial Infarction (STEMI) being the primary indication for percutaneous coronary intervention. Post-procedure complications includes significant bleeding (n = 6, 2.6%), myocardial infarction (n = 20, 8.9%), death (n = 2, 0.9%), transfer to another hospital (n = 12, 5.4%), and acute kidney injury (n = 16, 7.14%). The use of bare metal stents was significantly associated with transfer to other hospitals (AOR = 5; 95% CI = 1.69-10.29). Male gender (AOR = 0.09; 95% CI = 0.03-0.34) and a history of myocardial infarction (AOR = 10; 95% CI = 2.31-13.31) were linked to an increased risk of post-percutaneous coronary intervention death.</p><p><strong>Conclusion and recommendations: </strong>Our findings suggest that coronary artery stenosis (CAS) is more prevalent in older individuals and men. Chronic illnesses often coexist with coronary artery stenosis, thereby complicating the prognosis. Interestingly, men exhibited a lower risk of unfavorable outcomes compared to women. Adherence to procedural guidelines and effective management techniques are essential for improving patient outcomes following percutaneous coronary intervention.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 1","pages":"29-38"},"PeriodicalIF":1.3,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928886/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of threshold-loaded inspiratory muscle training and respiratory biofeedback on preserving inspiratory muscle strength and vital capacity after CABG: a randomized clinical trial. 阈值负荷的吸气肌训练和呼吸生物反馈对冠脉搭桥后保持吸气肌力量和肺活量的影响:一项随机临床试验。
IF 1.3 Pub Date : 2024-12-15 eCollection Date: 2024-01-01 DOI: 10.62347/JBMU4830
Bahareh Mehregan-Far, Sedigheh Sadat Naimi, Mohsen Abedi, Parsa Salemi, Seyed Ahmad Raeis-Sadat, Mahmood Beheshti-Monfared

Objectives: Postoperative pulmonary complications (POPC) are common after cardiac surgeries such as coronary artery bypass grafting (CABG) and are influenced by factors including anesthesia and surgical trauma. Inspiratory muscle training (IMT) with visual biofeedback may mitigate these complications. This study investigates the impact of threshold loading inspiratory muscle training (TL-IMT) combined with respiratory biofeedback on the dynamic strength of inspiratory muscles (S-index) in patients undergoing CABG surgery during their hospitalization phase.

Methods: A single-blind study was conducted with 38 CABG candidates at Shahid Modares Hospital, Tehran. Participants were randomized into two groups: the TL-IMT with biofeedback group and the placebo IMT group. TL-IMT exercises were performed at 30% of maximum dynamic inspiratory strength using the Power Breath K5 device, with visual biofeedback displayed on the screen. The placebo group performed the same exercises at minimal load without biofeedback. Both groups received standard respiratory physiotherapy. Measurements of S-index, peak inspiratory flow (PIF), and vital capacity (VC) were taken before surgery (T1), one day after surgery (T2), and at discharge (T3).

Results: Both groups showed significant changes, with a decrease from T1 to T2 and an increase from T2 to T3. In the study group, T3 values remained the same as at T1, while the placebo IMT group experienced a significant decrease. After surgery, both groups had a drop in the S-index. However, the study group saw more pronounced changes between T3-T2 and T3-T1 compared to the control group, although no significant difference was found between T2-T1. By the time of discharge, the TL-IMT group had higher S-index values than the placebo group, returning to preoperative levels. Additionally, the TL-IMT group showed improvements in PIF and VC.

Conclusion: TL-IMT with visual biofeedback effectively maintains dynamic inspiratory muscle strength and improves key pulmonary parameters in cardiac surgery patients. These findings suggest that integrating TL-IMT with biofeedback can enhance postoperative recovery and reduce the incidence of POPC.

目的:术后肺部并发症(POPC)是冠状动脉旁路移植术(CABG)等心脏手术后常见的并发症,受麻醉和手术创伤等因素的影响。吸气肌训练(IMT)与视觉生物反馈可以减轻这些并发症。本研究探讨阈值负荷吸气肌训练(TL-IMT)结合呼吸生物反馈对冠脉搭桥患者住院期吸气肌动态强度(s指数)的影响。方法:对德黑兰Shahid Modares医院的38例CABG候选者进行单盲研究。参与者被随机分为两组:生物反馈的TL-IMT组和安慰剂IMT组。使用Power Breath K5装置以最大动态吸气强度的30%进行TL-IMT练习,并在屏幕上显示视觉生物反馈。安慰剂组在没有生物反馈的情况下以最小负荷进行相同的锻炼。两组均接受标准的呼吸物理治疗。术前(T1)、术后1天(T2)和出院时(T3)分别测定s指数、吸气峰值流量(PIF)和肺活量(VC)。结果:两组均有明显变化,T1 - T2降低,T2 - T3升高。在研究组中,T3值与T1时相同,而安慰剂IMT组T3值明显下降。术后两组患者s指数均有下降。与对照组相比,研究组T3-T2和T3-T1的变化更为明显,但T2-T1之间无明显差异。出院时,TL-IMT组s指数高于安慰剂组,恢复到术前水平。此外,TL-IMT组在PIF和VC方面也有改善。结论:视觉生物反馈TL-IMT能有效维持心脏手术患者动态吸气肌力量,改善肺关键参数。这些结果表明,将TL-IMT与生物反馈相结合可以提高术后恢复,减少POPC的发生率。
{"title":"The impact of threshold-loaded inspiratory muscle training and respiratory biofeedback on preserving inspiratory muscle strength and vital capacity after CABG: a randomized clinical trial.","authors":"Bahareh Mehregan-Far, Sedigheh Sadat Naimi, Mohsen Abedi, Parsa Salemi, Seyed Ahmad Raeis-Sadat, Mahmood Beheshti-Monfared","doi":"10.62347/JBMU4830","DOIUrl":"10.62347/JBMU4830","url":null,"abstract":"<p><strong>Objectives: </strong>Postoperative pulmonary complications (POPC) are common after cardiac surgeries such as coronary artery bypass grafting (CABG) and are influenced by factors including anesthesia and surgical trauma. Inspiratory muscle training (IMT) with visual biofeedback may mitigate these complications. This study investigates the impact of threshold loading inspiratory muscle training (TL-IMT) combined with respiratory biofeedback on the dynamic strength of inspiratory muscles (S-index) in patients undergoing CABG surgery during their hospitalization phase.</p><p><strong>Methods: </strong>A single-blind study was conducted with 38 CABG candidates at Shahid Modares Hospital, Tehran. Participants were randomized into two groups: the TL-IMT with biofeedback group and the placebo IMT group. TL-IMT exercises were performed at 30% of maximum dynamic inspiratory strength using the Power Breath K5 device, with visual biofeedback displayed on the screen. The placebo group performed the same exercises at minimal load without biofeedback. Both groups received standard respiratory physiotherapy. Measurements of S-index, peak inspiratory flow (PIF), and vital capacity (VC) were taken before surgery (T1), one day after surgery (T2), and at discharge (T3).</p><p><strong>Results: </strong>Both groups showed significant changes, with a decrease from T1 to T2 and an increase from T2 to T3. In the study group, T3 values remained the same as at T1, while the placebo IMT group experienced a significant decrease. After surgery, both groups had a drop in the S-index. However, the study group saw more pronounced changes between T3-T2 and T3-T1 compared to the control group, although no significant difference was found between T2-T1. By the time of discharge, the TL-IMT group had higher S-index values than the placebo group, returning to preoperative levels. Additionally, the TL-IMT group showed improvements in PIF and VC.</p><p><strong>Conclusion: </strong>TL-IMT with visual biofeedback effectively maintains dynamic inspiratory muscle strength and improves key pulmonary parameters in cardiac surgery patients. These findings suggest that integrating TL-IMT with biofeedback can enhance postoperative recovery and reduce the incidence of POPC.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"14 6","pages":"375-383"},"PeriodicalIF":1.3,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744222/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142998636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American journal of cardiovascular disease
全部 Geobiology Appl. Clay Sci. Geochim. Cosmochim. Acta J. Hydrol. Org. Geochem. Carbon Balance Manage. Contrib. Mineral. Petrol. Int. J. Biometeorol. IZV-PHYS SOLID EART+ J. Atmos. Chem. Acta Oceanolog. Sin. Acta Geophys. ACTA GEOL POL ACTA PETROL SIN ACTA GEOL SIN-ENGL AAPG Bull. Acta Geochimica Adv. Atmos. Sci. Adv. Meteorol. Am. J. Phys. Anthropol. Am. J. Sci. Am. Mineral. Annu. Rev. Earth Planet. Sci. Appl. Geochem. Aquat. Geochem. Ann. Glaciol. Archaeol. Anthropol. Sci. ARCHAEOMETRY ARCT ANTARCT ALP RES Asia-Pac. J. Atmos. Sci. ATMOSPHERE-BASEL Atmos. Res. Aust. J. Earth Sci. Atmos. Chem. Phys. Atmos. Meas. Tech. Basin Res. Big Earth Data BIOGEOSCIENCES Geostand. Geoanal. Res. GEOLOGY Geosci. J. Geochem. J. Geochem. Trans. Geosci. Front. Geol. Ore Deposits Global Biogeochem. Cycles Gondwana Res. Geochem. Int. Geol. J. Geophys. Prospect. Geosci. Model Dev. GEOL BELG GROUNDWATER Hydrogeol. J. Hydrol. Earth Syst. Sci. Hydrol. Processes Int. J. Climatol. Int. J. Earth Sci. Int. Geol. Rev. Int. J. Disaster Risk Reduct. Int. J. Geomech. Int. J. Geog. Inf. Sci. Isl. Arc J. Afr. Earth. Sci. J. Adv. Model. Earth Syst. J APPL METEOROL CLIM J. Atmos. Oceanic Technol. J. Atmos. Sol. Terr. Phys. J. Clim. J. Earth Sci. J. Earth Syst. Sci. J. Environ. Eng. Geophys. J. Geog. Sci. Mineral. Mag. Miner. Deposita Mon. Weather Rev. Nat. Hazards Earth Syst. Sci. Nat. Clim. Change Nat. Geosci. Ocean Dyn. Ocean and Coastal Research npj Clim. Atmos. Sci. Ocean Modell. Ocean Sci. Ore Geol. Rev. OCEAN SCI J Paleontol. J. PALAEOGEOGR PALAEOCL PERIOD MINERAL PETROLOGY+ Phys. Chem. Miner. Polar Sci. Prog. Oceanogr. Quat. Sci. Rev. Q. J. Eng. Geol. Hydrogeol. RADIOCARBON Pure Appl. Geophys. Resour. Geol. Rev. Geophys. Sediment. Geol.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1